Longbow
Venture capital firm investing in high-growth technology companies.
Longevity Science Foundation
The Longevity Science Foundation (LSF) is a global 501(c)(3) nonprofit organization dedicated to extending the healthy human lifespan by funding critical scientific research aimed at preventing chronic and age-related diseases. Their mission is to bridge the gap between innovative longevity solutions and accessible treatments for everyone, as access to longevity-focused care is currently limited and exclusive. They address this by targeting areas such as predictive diagnostics, personalized medicine, artificial intelligence, and therapeutics. They also aim to support early-stage research and development in the space, and to foster collaboration across institutions. The LSF's funding strategy focuses on projects that are impactful and have a clear plan for translating research into accessible and actionable solutions, particularly those that enhance reproductive health and overall health outcomes. The organization emphasizes ethical considerations, transparency, and collaboration in its grant-making and operations, promoting a holistic approach to longevity.
Longfield Invest
Venture capital firm investing in high-growth technology companies.
Longliv Ventures
Venture capital firm investing in high-growth technology companies.
Longpan Investment
Venture capital firm investing in high-growth technology companies.
Longview Ventures
Venture capital firm investing in high-growth technology companies.
Longwall Venture Partners
Longwall Ventures invests in early-stage deeptech businesses that are harnessing the UK’s expertise in science R&D to address the global challenges of tomorrow. They focus on forming, shaping, and supporting businesses with big impact potential and global ambitions. Their funds have been investing in early-stage science, engineering, and health startups in the UK since 2008. Longwall's investment strategy centers around identifying and nurturing companies at the forefront of scientific and technological innovation. They seek out opportunities where UK-based research and development can be leveraged to create solutions for global problems. The firm provides more than just capital; they work closely with their portfolio companies to provide strategic guidance, operational support, and access to their network. Their approach is centered around creating lasting value and supporting companies in scaling their impact on a global stage.
Longwall Ventures
Longwall Ventures invests in early-stage deeptech businesses in the UK. They are specifically looking for companies that leverage the UK's strong science R&D capabilities to tackle significant global challenges.
Lugus Capital
Lugus Capital is an Irish real estate investment platform that partners with investors to deliver innovative solutions for transforming and regenerating the built environment. Their vision is to become Ireland's leading investment partner, actively shaping the real estate landscape. They achieve this through strategic insights, data-driven real estate analysis, market expertise, and innovative thinking, aiming to deliver exceptional returns and improved living standards. Lugus positions itself as a credible platform and a trusted custodian for international capital partners investing in the Irish property market. The firm invests, manages, and operates across commercial, residential, and healthcare real estate sectors. Their approach combines strategic investment with deep knowledge of capital markets and the extensive experience of their team. This multifaceted strategy has enabled Lugus to grow its AUM to €900 million, encompassing a diversified portfolio of assets across their target sectors. Lugus identifies and executes on investment strategies and opportunities to create value within the real estate sector. Their investment strategies are centered around residential (integrated property developer and operator), commercial (developer and operator platform), and healthcare real estate (developer and operator). They feature example investments such as Rathmines House (co-living) and Cork Street (details not fully available on the crawled pages).
Lumaux
Venture capital firm investing in high-growth technology companies.
Lumiares
Venture capital firm investing in high-growth technology companies.
Luminous Ventures
Luminous Ventures is a London-based venture capital firm that focuses on investing in Deep Tech companies. Their investment strategy centers around the application of innovative technologies specifically within the healthcare and life sciences sectors. The fund targeted companies located in both Europe and North America, aiming to support early-stage ventures that demonstrated substantial potential for growth and impact. Luminous Ventures primarily invested at the Seed and Series A stages, providing crucial capital and support to companies navigating the critical phases of development and scaling. This investment strategy reflects a commitment to identifying and nurturing promising deep tech startups at a point where strategic guidance and financial resources can be particularly impactful. The firm's focus on Deep Tech within healthcare and life sciences suggests a belief in the transformative power of technological advancements in these sectors. Their investment approach was designed to support companies that are pushing the boundaries of innovation and addressing significant challenges within these industries. Notably, the fund is now fully deployed and is not currently making any new investments. This indicates that Luminous Ventures is currently focused on supporting its existing portfolio companies and realizing the potential of its past investments.
Lumira Ventures
Lumira Ventures is a North American life sciences venture capital firm focused on delivering exceptional returns for investors by investing in and helping to create value in transformative life sciences companies. They measure their performance not only by financial returns but also by the impact they have on patients and healthcare systems worldwide. Their core team has worked together for over a decade, developing a unique ability to cultivate winning investment themes while closely monitoring the North American healthcare landscape. Lumira prides itself on helping top-tier biotherapeutic and medical device companies realize their vision. Lumira Ventures aims to empower a better tomorrow for patients by partnering with mission-driven entrepreneurs to build transformative life sciences companies. They focus on developing and commercializing impactful products for patients. The firm's investment approach is centered around identifying and supporting companies that can address significant unmet medical needs and improve patient outcomes. Their past investments have resulted in a substantial impact, including touching over 1 billion patient lives, targeting over 40 diseases, and contributing to the development of over 50 approved products. Portfolio companies have collectively raised over $6 billion in capital, reflecting the firm's ability to attract follow-on investment and support the growth of its portfolio companies. The firm also emphasizes its commitment to supporting the broader life sciences ecosystem, as demonstrated by their partnership with The Terry Fox Foundation to launch The Cancer Breakthrough Fund. Gerry Brunk, a Managing Director at Lumira, is a member of the Focused Ultrasound Foundation's Council. These activities highlight the firm's dedication to driving innovation and improving patient care beyond their direct investments.
Lumière AI Ventures
Lumiere AI Ventures, operating under the parent company Latitude, focuses on uniting intelligence and creativity by turning data into knowledge and a vision of what's ahead. They aim to help clients offer unique content that truly connects with audiences through their Lumiere platform, a video intelligence engine. This platform provides deep content analytics and audience insights, making video more intelligent, interactive, and collaborative. They offer interactive feedback tools such as emoji reactions, hotspot questions, and AI-powered Conversations to collect both qualitative and quantitative insights as viewers watch content. The firm specializes in content assessment, ad and brand testing, and strategic audience research. They leverage Lumiere to immerse people in content and gather real-time feedback. Their platform allows for multi-video testing, comparison of audiences over time, and flexible feedback tools depending on research goals. Lumiere facilitates the transformation of insights into assets, enabling users to output data sections or summaries in various formats (interactive dashboards, PNGs, GIFs, CSV files). Latitude emphasizes collaborative autonomy within small, dynamic teams and a learning environment that supports continuous personal and professional development. Their remote-first approach offers flexible hours and locations, complemented by personal and family benefits. They are looking for research analysts, data scientists, business strategists, and application developers who are smart, curious, innovative, adaptive, and human. Lumiere enhances decision-making through seamless integration of GenAI for conversational insights and summaries. Clear KPIs, such as reduced setup time and improved feedback quality, demonstrate the platform's impact. They are committed to designing tools that help advertising and brand researchers, strategists, and marketers not only get the insights they need but also enjoy the process of obtaining them.
Lunate
Venture capital firm investing in high-growth technology companies.
Lundbeckfond Invest
The Lundbeck Foundation operates with a dual mission: to improve lives and steer society in a healthier direction through funding biomedical sciences research, particularly in neuroscience, and to generate attractive financial returns through long-term strategic ownerships in healthcare enterprises. Their strategy, "Bringing Discoveries to Lives", aims to double their wealth by 2030 to double their grants. This includes making Denmark a frontrunner in neuroscience, improving interaction between universities, hospitals, and businesses by investing in talented researchers, entrepreneurs, and innovation, developing healthcare businesses into global leaders, and becoming an active voice in public debate to contribute to the development and internationalization of Danish health research and business culture.
Lundbeckfonden BioCapital
Lundbeckfonden is an enterprise foundation with a dual mission: to grant funds for biomedical sciences research, particularly neuroscience, and to actively invest in healthcare businesses. Their strategy, "Bringing Discoveries to Lives," aims to double grants for research in Denmark and develop a clearer focus on the brain. They strive to improve interaction between universities, hospitals, and businesses by investing in talented researchers, entrepreneurs, and innovation. The foundation develops healthcare businesses and helps them become global leaders by taking on the role of a competent and engaged owner, while generating attractive financial returns to fund their increasing grant portfolio and ensure long-term economic robustness and growth. They also aim to become an active voice in public debate, contributing to the development and internationalisation of Danish health research and business culture, and broadening society’s understanding of the brain and its diseases. Lundbeckfonden's investment strategy emphasizes long-term value creation. They focus on strategic ownerships in established healthcare companies and investments in biotech companies. The foundation seeks to improve lives and steer society in a healthier direction, with an ambition for Denmark to become a leading research nation in healthcare. They aim to fund research that promotes a better understanding of the brain and better prevention, diagnosis, and treatment of brain disorders. The foundation's commitment to social responsibility is reflected in their activities as an owner, investor, and grant-maker. They are committed to transparency and adhere to high standards of governance. They report to the UN Global Compact on their activities to comply with and raise awareness of responsible business principles. The Lundbeck Foundation also implements a whistleblower scheme to promote transparency and accountability in their operations. Their strategy is guided by the principle of creating powerful ripple effects that bring discoveries to lives. This means investing actively in business and science at the frontiers of their fields, fostering innovation and driving breakthroughs for the benefit of society. They prioritize collaboration between research and business, aiming to translate scientific discoveries into innovative healthcare solutions and new healthcare companies in Denmark.
Luno
Luno aims to build a better financial system for everyone, everywhere by providing an accessible, transparent, and global platform for investing in cryptocurrency. They focus on simplicity, security, and reliable support to cater to a broad range of users, from individuals to professional traders and institutions. The company offers a suite of tools to build a crypto portfolio safely, including options to choose from rigorously-assessed cryptocurrencies, earn crypto rewards with staking, and explore multiple investments in one transaction. Luno operates on a 1:1 asset storage basis and provides monthly proof of reserves, emphasizing transparency and building trust. They are focused on the future of finance, enabling users to trade, invest, and manage their wealth through cryptocurrency. Luno serves a global audience across 40+ countries, making cryptocurrency investment more accessible and user-friendly.
Lux Media Investments
Lux Media Investments, based in Luxembourg, focuses on principal-protected, fixed-income structured notes within the media and technology sectors. Their investment strategy aims to drive groundbreaking initiatives and generate significant social impact alongside sustainable financial returns. They target enterprises poised for global breakthroughs, led by visionary leaders, and with paths towards IPOs or strategic acquisitions. They prioritize scalable, disruptive technologies and concepts, offering a combination of stability, profitability, and social value. The firm is managed by Global Media Investment Fund LLC and guided by advisors in media and tech.
Luxembourg Business Angel Network (LBAN)
Venture capital firm investing in high-growth technology companies.
Luxembourg Finance House
Venture capital firm investing in high-growth technology companies.
Lvl Group SARL
Venture capital firm investing in high-growth technology companies.
Lynx Financial (HK) Limited
Lynx Financial is a healthcare and life science-focused fund that invests in innovative technologies to benefit patients worldwide. They aim to advance sciences and medicine while achieving commercial success and economic returns. The firm comprises physicians, scientists, entrepreneurs, consultants, and investment professionals sharing a common goal of driving progress in the healthcare sector.
L’Oréal Fund For Nature Regeneration
Venture capital firm investing in high-growth technology companies.